Citadel Advisors’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-13,184
| Closed | -$74.8K | – | 7196 |
|
2025
Q1 | $74.8K | Buy |
+13,184
| New | +$74.8K | ﹤0.01% | 5244 |
|
2024
Q1 | – | Sell |
-610
| Closed | -$8.26K | – | 6927 |
|
2023
Q4 | $8.26K | Buy |
+610
| New | +$8.26K | ﹤0.01% | 5561 |
|
2023
Q3 | – | Sell |
-304
| Closed | -$9.56K | – | 6627 |
|
2023
Q2 | $9.56K | Sell |
304
-78
| -20% | -$2.45K | ﹤0.01% | 5383 |
|
2023
Q1 | $8.9K | Buy |
+382
| New | +$8.9K | ﹤0.01% | 5540 |
|
2022
Q4 | – | Sell |
-285
| Closed | -$6K | – | 6817 |
|
2022
Q3 | $6K | Sell |
285
-170
| -37% | -$3.58K | ﹤0.01% | 5689 |
|
2022
Q2 | $9K | Buy |
+455
| New | +$9K | ﹤0.01% | 5833 |
|
2021
Q4 | – | Sell |
-1,153
| Closed | -$38K | – | 7310 |
|
2021
Q3 | $38K | Buy |
+1,153
| New | +$38K | ﹤0.01% | 6190 |
|
2020
Q4 | – | Sell |
-696
| Closed | -$20K | – | 5682 |
|
2020
Q3 | $20K | Buy |
696
+377
| +118% | +$10.8K | ﹤0.01% | 4526 |
|
2020
Q2 | $11K | Sell |
319
-117
| -27% | -$4.03K | ﹤0.01% | 4536 |
|
2020
Q1 | $14K | Buy |
+436
| New | +$14K | ﹤0.01% | 4704 |
|